This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for D...Show More
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations